Skip to main content

Table 2 Baseline characteristics of the patients

From: Outcomes after EVAR in females are similar to males

Features

Unmatched cohort

Matched cohort

Female patients (n = 26)

Male patients (n = 223)

p value

Female patients (n = 26)

Male patients (n = 26)

p value

Age, years, median (IQR)

75 (68–83)

69 (65–74)

0.014

75 (68–83)

73 (69–77)

0.687

Diabetes mellitus

12 (46.2)

54 (24.2)

0.016

12 (46.2)

11 (42.3)

0.780

Hypertension

24 (92.3)

146 (65.5)

0.005

24 (92.3)

24 (92.3)

1.000

Hyperlipidemia

8 (30.8)

65 (29.1)

0.864

8 (30.8)

6 (23.1)

0.532

Pulmonary disease

10 (38.5)

73 (32.7)

0.558

10 (38.5)

8 (30.8%)

0.560

Renal insufficiency

0

26 (11.7)

0.087

0

2 (7.7%)

0.490

Peripheral vascular disease

1 (3.8)

21 (9.4)

0.485

1 (3.8)

2 (7.7%)

1.000

Coronary artery disease

5 (19.2)

108 (48.4)

0.005

5 (19.2)

4 (15.4%)

1.000

CABG

0

52 (23.3)

0.006

0

0

History of malignancy

0

14 (6.3)

0.373

0

0

Previous abdominal surgery

5 (19.2)

16 (7.2)

0.053

5 (19.2)

2 (7.7)

0.419

Body surface area, m2, mean ± SD

1.75 ± 0.24

1.88 ± 0.17

0.016

1.75 ± 0.24

1.85 ± 0.12

0.033

Aortic size index, mean ± SD

4.12 ± 0.84

3.47 ± 0.72

0.002

4.12 ± 0.84

3.67 ± 0.56

0.011

Maximum aneurysm diameter, mm, median (IQR)

62 (59–75)

60 (55–70)

0.273

62 (59–75)

63 (57–75)

0.953

Ejection fraction, % median (IQR)

55 (53–57)

55(48–58)

0.333

55 (53–57)

55 (52–60)

0.360